Alzamend Neuro, Inc.
ALZNNasdaqCIK 1677077HealthcareFiscal year ends Apr 30
Reports and events: 121 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2910:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-26-012132 |
| 2026-09-1020:30 ET | 10-Q | Quarterly reportPeriod 2026-07-31 | 0001214659-26-011572 |
| 2026-08-2120:30 ET | S-1 | Registration statement | 0001214659-26-010726 |
| 2026-08-0320:30 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001214659-26-009469 |
| 2026-07-2220:30 ET | 10-K | Annual reportPeriod 2026-04-30 | 0001214659-26-008832 |
| 2026-07-2120:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001214659-26-008772 |
| 2026-04-1720:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001214659-26-004806 |
| 2026-03-2020:30 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001214659-26-003620 |
| 2026-03-1120:30 ET | 10-Q | Quarterly reportPeriod 2026-01-31 | 0001214659-26-003166 |
| 2026-03-0621:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001214659-26-002932 |
| 2026-02-2622:12 ET | DEF 14A | Proxy statementPeriod 2026-04-17 | 0001214659-26-002583 |
| 2025-12-0921:30 ET | 10-Q | Quarterly reportPeriod 2025-10-31 | 0001214659-25-017793 |
| 2025-11-1821:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001214659-25-016885 |
| 2025-10-1420:51 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001214659-25-014950 |
| 2025-10-0920:30 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001214659-25-014818 |
| 2025-10-0701:53 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-014750 |
| 2025-10-0301:37 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-014630 |
| 2025-09-3000:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-014424 |
| 2025-09-2501:37 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-014211 |
| 2025-09-2520:30 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001214659-25-014200 |
| 2025-09-2320:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-014057 |
| 2025-09-1020:30 ET | 10-Q | Quarterly reportPeriod 2025-07-31 | 0001214659-25-013609 |
| 2025-08-0100:52 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-011394 |
| 2025-08-0120:30 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001214659-25-011357 |
| 2025-07-2320:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001214659-25-010830 |
| 2025-07-2220:30 ET | 10-K | Annual reportPeriod 2025-04-30 | 0001214659-25-010763 |
| 2025-07-0920:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001214659-25-010209 |
| 2025-05-0820:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-25-007204 |
| 2025-04-2520:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001214659-25-006405 |
| 2025-03-2720:30 ET | S-1/A | Registration statement, amended | 0001214659-25-004902 |
| 2025-03-1321:00 ET | DEF 14A | Proxy statementPeriod 2025-04-25 | 0001214659-25-004335 |
| 2025-03-1020:30 ET | 10-Q | Quarterly reportPeriod 2025-01-31 | 0001214659-25-004123 |
| 2025-03-0321:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001214659-25-003727 |
| 2025-02-2821:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001214659-25-003658 |
| 2024-12-1221:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001214659-24-020439 |
| 2024-12-1121:30 ET | 10-Q | Quarterly reportPeriod 2024-10-31 | 0001214659-24-020264 |
| 2024-10-1520:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-24-017549 |
| 2024-10-0320:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001214659-24-017141 |
| 2024-09-1120:30 ET | 10-Q | Quarterly reportPeriod 2024-07-31 | 0001214659-24-016346 |
| 2024-07-3120:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-24-013382 |
| 2024-07-3020:30 ET | 10-K | Annual reportPeriod 2024-04-30 | 0001214659-24-013191 |
| 2024-07-1220:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-24-012340 |
| 2024-07-0820:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001214659-24-012079 |
| 2024-07-0320:31 ET | S-1/A | Registration statement, amended | 0001214659-24-011977 |
| 2024-06-2620:46 ET | S-1/A | Registration statement, amended | 0001214659-24-011445 |
| 2024-06-0320:30 ET | S-1 | Registration statement | 0001214659-24-010447 |
| 2024-05-3120:59 ET | DEF 14A | Proxy statementPeriod 2024-07-08 | 0001214659-24-010336 |
| 2024-05-2220:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-24-009785 |
| 2024-05-1520:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-24-009345 |
| 2024-05-1320:30 ET | 8-K | 9.01 Financial statements and exhibits | 0001214659-24-008914 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.